- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06979570
Spaceflight Performance Enhancement Study Using Wearable Technology
This groundbreaking study, led by Massachusetts General Hospital in collaboration with MIT, investigates a novel approach to optimizing astronaut performance during long-duration space missions. The Personalized Performance Optimization Platform (P-POP) represents a significant advancement in space medicine, addressing critical challenges faced by crews venturing beyond Earth's orbit.
Space exploration presents unique psychological and physiological stressors that can impair cognitive function:
- High workload demands in confined spaces
- Sleep disturbances and circadian rhythm disruptions
- Limited sensory stimulation
- Extended isolation from family and support systems
- Communication delays with Earth-based teams
The study focuses on three innovative, non-invasive countermeasures to maintain peak performance:
- Auditory Stimulation: Using sound cues and music to regulate attention and arousal levels
- Haptic Feedback: Employing vibration patterns to enhance alertness and motor coordination
- Light Modulation: Adjusting lighting characteristics to influence cognitive state and circadian rhythms
Participants will use the AttentivU wearable device, which continuously monitors brain activity (EEG), eye movements, and physical activity through advanced sensors. This technology can detect crucial psychological states including attention levels, fatigue, cognitive load, and stress in real-time.
The research will evaluate participants' performance on standardized cognitive tests including the N-Back Task (measuring working memory) and Psychomotor Vigilance Test (assessing sustained attention). These assessments will occur over a 6-week period, comparing performance with and without the countermeasure interventions.
This study has important implications beyond space exploration. The technologies being developed could benefit:
- Individuals with attention disorders
- Shift workers managing circadian disruptions
- Patients recovering from neurological conditions
- Anyone requiring optimized cognitive performance in high-stress environments
The research addresses several critical gaps in our understanding of human performance optimization. While previous studies have shown that environmental modifications can influence psychological state, this investigation directly connects these interventions to measurable improvements in complex task performance. The findings could revolutionize how we maintain cognitive function in extreme environments, from space stations to submarines to hospital ICUs.
For potential participants, the study offers a unique opportunity to contribute to cutting-edge research that bridges neuroscience, psychology, and space technology. The non-invasive nature of the interventions makes it accessible to healthy adults aged 18-64, without requiring any specialized background or skills.
The importance of this research cannot be overstated as humanity prepares for extended missions to the Moon and Mars. Maintaining crew health and performance during these missions will be paramount to mission success and astronaut well-being. This study represents a proactive approach to solving challenges before they become operational problems, potentially preventing performance-related incidents during critical mission phases.
Upcoming Clinical Trials
-
NCT07622186Not yet recruitingNon-Small Cell Lung Cancer
-
NCT07622199Not yet recruiting
-
NCT07622212Recruiting
-
NCT07622225Not yet recruiting
-
NCT07622238RecruitingKidney Calculi | Urolithiasis
-
NCT07622251Not yet recruitingSystem Lupus Erythematosus(SLE)
-
NCT07622277Recruiting
-
NCT07622290Not yet recruitingObesity-associated Asthma
-
NCT07622303Not yet recruitingParkinson's Disease
-
NCT07622316RecruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)
-
NCT07622329Not yet recruitingThrombocytopenic Purpura, Immune
-
NCT07622342Not yet recruitingGeneralized Myasthenia Gravis